All Posts IMO. Do your own research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GLTU and all shareholders. Let’s hope this makes a positive impact in the world
Awesome news!!! Let’s go XXII
Looking forward to more updates and info from XXII
Congratulations to all shareholders!!! Especially those that have held for a long time
Maybe they have more info than that?
In any case, I think a PR is appropriate on its purpose, timing, etc.
Did XXII put out a PR on it? If not, perhaps they should?
Would be nice to get an update on all the Q4 2021 milestones this week. Especially the Buc trials
Would be nice to see MRTP approval soon and in 2021.
GLTA shareholders
Would be nice to get an update from the CEO.
GLTA shareholders
Looking forward to good news soon.
GLTA shareholders
Well, perhaps that could make a big difference?
Curious if they had many shareholders with numerous restricted shares and shareholders like NGCG?
I figured that and perhaps that’s what they’re waiting for before any big news?
Curious when those restricted shares issued in February become unrestricted
Thanks for the info. Let’s hope he does something and soon
GLTA shareholders
Hopefully MRTP is approved soon.
GLTA shareholders
Perhaps the CEO can provide an update to shareholders?
Let’s hope he does something positive for shareholders soon. Ideally in 2021
GLTU
Interesting. Wonder if Daniel is doing anything to increase shareholders value and equity?
Would be great to get positive anti inflammatory results at 800 patients and DSMB giving the nod for EUA at 800.
If they have enough info at 800 for the potential viral load and anti viral properties that’s great. If not,
it would be good if they recommend EUA at 800 and let the trials continue to 1,000 to address the potential viral load and anti viral properties and usage.
Yes. I heard that. I’m wondering if they would allow for an EUA at 800 patients as an anti inflammatory while they continue to analyze the viral loading and potential anti viral properties and then ANOTHER EUA at 1,000 patients for both anti inflammatory AND anti viral usage?
Very nice. Good questions and thoughts from BMT.
I’m not sure if I missed it; however, I wonder if the results at 800 patients were good if the DSMB would recommend going for EUA immediately while continuing the trials to 1,000 patients for the antiviral aspects including the additional viral load testing and analysis?
Nice. Looking forward to good news soon
GLTA shareholders
Looking forward to EUA in 2021
Sounds interesting and maybe something positive will happen in the next few years?
Looks like NGCG is now Pink current.
That would be a good start. Would like to see RVVTF getting back to $0.4+ soon
That’s good. Maybe Pink current next?
Nice summary. I just stickied it
Looks like the article was updated and the word “potentially” removed from Q4
Perhaps a program manager could have helped? Wonder if there’s anything they can do at this point other than wait?
Good points. It’s usually good to be first and perhaps even more so here.
What else can RVVTF do at this point aside from sitting and waiting?
GLTA shareholders
It appears they still need to address something with OTCM to remove that notice
In any case, there appears to be some delays in the trials for whatever reason. Perhaps this is normal or maybe there’s some adjustments that can be made?
Wonder if RVVTF is aware of these possible issues as well?
Amazing. Hopefully it’s addressed soon
Looks like another update today. Verified Profile OTCM
Looks like fins updated again today.